<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02619656</url>
  </required_header>
  <id_info>
    <org_study_id>55102</org_study_id>
    <nct_id>NCT02619656</nct_id>
  </id_info>
  <brief_title>A Trial of Supplemental CO2 Versus Room Air in Percutaneous Endoscopic Gastrostomy</brief_title>
  <official_title>Insufflation With Carbon Dioxide Reduces Pneumoperitoneum After Percutaneous Endoscopic Gastrostomy (PEG): A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that using carbon dioxide for PEG placement versus using room
      air will decrease post-procedure pneumoperitoneum as well as improve post-procedure
      bloating/pain, and waist circumference.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background and study aims: Pneumoperitoneum following PEG placement has been reported in up
      to 60% of cases, and while usually benign and self-limited, it can lead to evaluation for
      suspected perforation. This study was designed to determine whether using CO2 compared to
      ambient air for insufflation during PEG reduces post-procedure pneumoperitoneum.

      Patients and Methods: Prospective, double blind, randomized trial of 35 consecutive patients
      undergoing PEG at a single academic medical center. Patients were randomized to insufflation
      with CO2 or ambient air. Primary outcome was pneumoperitoneum determined by left-lateral
      decubitus abdominal x-rays 30 min after PEG placement. Secondary endpoints included abdominal
      distention, pain, and bloating.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-procedure pneumoperitoneum</measure>
    <time_frame>left-lateral decubitus abdominal x-rays 30 min after PEG placement.</time_frame>
    <description>Frequency of post pneumoperitoneum determined by left-lateral decubitus abdominal x-rays 30 min after PEG placement.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Pneumoperitoneum</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to insufflation with CO2.
Intervention: CO2 Insufflation with CO2Efficient Endoscopic Insufflator on managed flow setting at 3.4 L/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to insufflation with ambient air.
Intervention: Ambient air insufflation with Evis Exera 111 CLV-190 on medium air flow setting 0.68 L/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2 insufflation</intervention_name>
    <description>Patients were randomized to insufflation with CO2.</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>CO2Efficient Endoscopic Insufflator on flow setting 3.4L/min</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ambient air insufflation</intervention_name>
    <description>Patients were randomized to insufflation with ambient air.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Evis Exera 111 CLV-190 on medium air flow setting 0.68L/min</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants must be over the age of 18 and need a percutaneous endoscopic gastrostomy

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Murphy, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Utah SOM</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John C Fang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah SOM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Utah SOM</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2015</study_first_submitted>
  <study_first_submitted_qc>November 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2015</study_first_posted>
  <last_update_submitted>November 30, 2015</last_update_submitted>
  <last_update_submitted_qc>November 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>John C. Fang, M.D.</investigator_full_name>
    <investigator_title>Chief, Division of Gastroenterology, Hepatology and Nutrition</investigator_title>
  </responsible_party>
  <keyword>PEG</keyword>
  <keyword>CO2 insufflation</keyword>
  <keyword>Room Air insufflation</keyword>
  <keyword>pneumoperitoneum</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumoperitoneum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

